Relief Therapeutics Holding SA (SWX: RLF)

RLF Revenue

Relief Therapeutics Holding had revenue of 3.01M CHF in the half year ending December 31, 2023, a decrease of -9.36%. This brings the company's revenue in the last twelve months to 8.60M, up 45.04% year-over-year. In the year 2023, Relief Therapeutics Holding had annual revenue of 6.03M, down -0.79%.

• Revenue (ttm): 8.60M
• Revenue Growth: +45.04%
• P/S Ratio: 5.55
• Revenue / Employee: 175.47K
• Employees: 49
• Market Cap: 47.90M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	6.03M	-48.00K	-0.79%
Dec 31, 2022	6.08M	2.76M	83.11%
Dec 31, 2021	3.32M	-	-
Dec 31, 2020	-	-	-
Dec 31, 2019	-	-	-